Regulon

Regulon: R-2509

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
133.2651719Pr-0Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
9168 ENSG00000034510 TMSB10 P63313
966 ENSG00000085063 CD59 P13987
3956 ENSG00000100097 LGALS1 P09382
2184 ENSG00000103876 FAH P16930
10312 ENSG00000110719 TCIRG1 Q13488
4179 ENSG00000117335 CD46 P15529
6237 ENSG00000126458 RRAS P10301
51303 ENSG00000134285 FKBP11 Q9NYL4
8826 ENSG00000140575 IQGAP1 P46940
840 ENSG00000165806 CASP7 P55210
25825 ENSG00000182240 BACE2 Q9Y5Z0
302 ENSG00000182718 ANXA2 P07355
7106 ENSG00000214063 TSPAN4 O14817

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
DAVANATLGALS3UnknownINHIBITORGalectin-1 inhibitor20
EMRICASANCASP4Small moleculeINHIBITORCaspase inhibitor20

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-2509

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-00363COL6A3up-regulatesPLAG1activatesR-250954Drugs (2)

Regulator Drugs (0)

Regulon Drugs (2)

DAVANAT, EMRICASAN

CMF-01153ZNF292down-regulatesPLAG1activatesR-250952Drugs (2)

Regulator Drugs (0)

Regulon Drugs (2)

DAVANAT, EMRICASAN

CMF-05353AMAC1down-regulatesPLAG1activatesR-250951Drugs (2)

Regulator Drugs (0)

Regulon Drugs (2)

DAVANAT, EMRICASAN

CMF-05790ADAMTS19down-regulatesPLAG1activatesR-250953Drugs (2)

Regulator Drugs (0)

Regulon Drugs (2)

DAVANAT, EMRICASAN

CMF-09289RP1down-regulatesPLAG1activatesR-250953Drugs (2)

Regulator Drugs (0)

Regulon Drugs (2)

DAVANAT, EMRICASAN

CMF-19596NF1up-regulatesPLAG1activatesR-250954Drugs (2)

Regulator Drugs (0)

Regulon Drugs (2)

DAVANAT, EMRICASAN

CMF-25114IQSEC3down-regulatesPLAG1activatesR-250951Drugs (2)

Regulator Drugs (0)

Regulon Drugs (2)

DAVANAT, EMRICASAN

CMF-28454MYO9Bdown-regulatesPLAG1activatesR-250954Drugs (2)

Regulator Drugs (0)

Regulon Drugs (2)

DAVANAT, EMRICASAN

CMF-29137FOLH1Bdown-regulatesPLAG1activatesR-250952Drugs (2)

Regulator Drugs (0)

Regulon Drugs (2)

DAVANAT, EMRICASAN